课题基金 / 基金详情

项目摘要

项目成果

MARCELO JACOBS-LORENA的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):与无法忍受的疟疾负担的斗争仅限于使用杀死蚊子媒介的杀虫剂和杀死人体内寄生虫的药物。考虑到最近估计感染疟疾的人数超过5亿(几乎每12人中就有1人),迫切需要采用新的手段防治这一疾病。我们建议开发一种新的策略来防止疟疾寄生虫通过按蚊传播,基于对这些昆虫肠道中的细菌进行基因改造。我们将详细评估两种候选细菌(Pantoea agglomerans和Asaia sp.)定殖幼虫和成蚊的能力以及它们从一代垂直传播到下一代的能力。我们将开发强大的方法,从每种细菌中分泌抗疟疾效应蛋白,以确保效应蛋白能够到达寄生虫或中肠上皮上的预期目标。将评估不同菌株分泌效应蛋白对蚊子体内寄生虫发育的影响。利用从产生单一效应器的工程菌株中获得的数据,我们将创建一个结合多种效应器的菌株的最佳组合,以获得最大功效。鉴于这种资助机制在时间框架上受到限制,尽管与相关监管机构(US-EPA)的讨论已经在进行中,但没有提出现场试验的建议。这项研究预计将导致开发一种新的武器,可以与传统的控制策略(药物、杀虫剂、疫苗)结合使用,以对抗疟疾。
英文摘要
DESCRIPTION (provided by applicant): The fight against the intolerable burden of malaria is restricted to the use of insecticides that kill the mosquito vector and drugs that kill the parasite in humans. Considering that recent estimates place the number humans infected with malaria at over 500 million (nearly 1 in 12 humans), the introduction of new means to counter the disease is urgently needed. We propose to develop a novel strategy to prevent the spread of malaria parasites by anopheline mosquitoes, based on genetic modification of bacteria that inhabit the gut of these insects. We will evaluate in detail the ability of two candidate bacterial species (Pantoea agglomerans and Asaia sp.) to colonize larval and adult mosquitoes and their ability to be transmitted vertically from one generation to the next. We will develop robust methods to secrete antimalarial effector proteins from each bacterial species to ensure that the effector proteins will reach the intended targets on the parasite or on the midgut epithelium. Different bacterial strains that secrete effector proteins will be evaluated for their efficacy to interfere with parasite development in the mosquito. Using the data obtained from engineered bacterial strains producing single effectors, we will create an optimal combination of strains that combine multiple effectors for maximum efficacy. Given that this funding mechanism is restricted in its time frame, no field trials are proposed although discussions with the relevant regulatory agency (US-EPA) are already underway. This research is expected to lead to the development of a novel weapon that can be used in combination with traditional control strategies (drugs, insecticides, vaccines) to combat malaria. PUBLIC HEALTH RELEVANCE: Malaria is one of the deadliest infectious diseases and kills an estimated 2 million persons every year. The mosquito is the obligatory vector for transmission. This project will devise new ways to interfere with the mosquito capacity to transmit the parasite, by genetically modifying bacteria that live in the mosquito midgut.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular mechanisms of Plasmodium fertilization
  • 批准号:
    9212860
  • 项目类别:
  • 资助金额:
    $40.8万
  • 财政年份:
    2016
  • 负责人:
    MARCELO JACOBS-LORENA
  • 依托单位:
Molecular mechanisms of Plasmodium fertilization
  • 批准号:
    10064068
  • 项目类别:
  • 资助金额:
    $40.94万
  • 财政年份:
    2016
  • 负责人:
    MARCELO JACOBS-LORENA
  • 依托单位:
Characterization of Plasmodium GAPDH as a candidate for development of a malaria pre-erythrocytic vaccine
  • 批准号:
    9228326
  • 项目类别:
  • 资助金额:
    $24.3万
  • 财政年份:
    2016
  • 负责人:
    MARCELO JACOBS-LORENA
  • 依托单位:
Brain vascular dysfunction in cerebral malaria
  • 批准号:
    9281895
  • 项目类别:
  • 资助金额:
    $48.16万
  • 财政年份:
    2015
  • 负责人:
    MARCELO JACOBS-LORENA
  • 依托单位:
海外基金